rs4833837
From SNPedia
| Orientation | plus |
| Stabilized | plus |
| Geno | Mag | Summary |
|---|---|---|
| (G;G) | 0 | common in clinvar |
| Make rs4833837(A;A) |
| Make rs4833837(A;G) |
| Reference | GRCh38 38.1/141 |
| Chromosome | 4 |
| Position | 122615808 |
| Gene | IL21 |
| is a | snp |
| is | mentioned by |
| dbSNP | rs4833837 |
| dbSNP (classic) | rs4833837 |
| ClinGen | rs4833837 |
| ebi | rs4833837 |
| HLI | rs4833837 |
| Exac | rs4833837 |
| Gnomad | rs4833837 |
| Varsome | rs4833837 |
| LitVar | rs4833837 |
| Map | rs4833837 |
| PheGenI | rs4833837 |
| Biobank | rs4833837 |
| 1000 genomes | rs4833837 |
| hgdp | rs4833837 |
| ensembl | rs4833837 |
| geneview | rs4833837 |
| scholar | rs4833837 |
| rs4833837 | |
| pharmgkb | rs4833837 |
| gwascentral | rs4833837 |
| openSNP | rs4833837 |
| 23andMe | rs4833837 |
| SNPshot | rs4833837 |
| SNPdbe | rs4833837 |
| MSV3d | rs4833837 |
| GWAS Ctlg | rs4833837 |
| GMAF | 0.1997 |
| Max Magnitude | 0 |
| ? | (A;A) (A;G) (G;G) | 28 |
|---|---|---|
|
| ||
[PMID 24389496] Interleukin (IL)-21 promoter polymorphism increases the risk of thyroid cancer in Chinese population
[PMID 18254984
] Screening of functional and positional candidate genes in families with common variable immunodeficiency.
[PMID 19546505] IL-21 drives secondary autoimmunity in patients with multiple sclerosis, following therapeutic lymphocyte depletion with alemtuzumab (Campath-1H).
[PMID 20184734] The 4q27 locus and prostate cancer risk.
[PMID 24879484] Interleukin-21 Polymorphism Affects Gene Expression and is Associated with Risk of Ischemic Stroke
| ClinVar | |
|---|---|
| Risk | rs4833837(A;A) |
| Alt | rs4833837(A;A) |
| Reference | Rs4833837(G;G) |
| Significance | Non-pathogenic |
| Disease | not specified |
| Variation | info |
| Gene | IL21 |
| CLNDBN | not specified |
| Reversed | 0 |
| HGVS | NC_000004.11:g.123536963G>A |
| CLNSRC | |
| CLNACC | RCV000454435.1, |
